Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Wayne State University
- Study ID
- NCT07793097
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 20 Years
- Healthy Volunteers
- Not accepted
Interventions
- Mindfulness-Based Stress Reduction - Virtual Reality — BEHAVIORALParticipants will receive group-delivered MBSR adapted for emerging adults with type 1 diabetes and virtual delivery including virtual reality technology. The intervention consists of instruction and practice in meditation, use of mindfulness techniques, the mind-body connection, and group discussions focused on mindfulness practice. MBSR intervention content includes 1) practicing a variety of mindfulness meditations, including sitting meditation, walking meditation, body scan, and mindful movement/gentle yoga; 2) learning to pay attention to, observe and describe moment-to moment experience in a way that promotes acceptance; 3) understanding stress reactions (stress symptoms, causes, effects) and how to create a mindful response to stressful situations; and 4) facilitators and barriers to applying mindfulness to everyday activities including eating, listening, communicating, walking and other activities.
- Stress tip sheet — OTHERParticipants will receive an educational stress management tip sheet developed by the American Diabetes Association. The resource provides information about the relationship between stress and diabetes, strategies for recognizing signs of stress, and practical techniques for coping with stress, including relaxation, physical activity, social support, and healthy self-care behaviors.
Study Details
The goal of this study is to learn if Mindfulness-Based Stress Reduction (MBSR) can be delivered using virtual reality (VR) technology to emerging adults (youth 16-20 years old) with type 1 diabetes and high levels of stress reactivity. If successful, MBSR-VR has the potential to reach many people who may be living in different places who might not have access to programs like MBSR. This is important because young adults with a chronic illness like diabetes and high levels of stress have been shown to have worse health than young adults with lower stress and young adults without diabetes. This study has not been designed to determine if MBSR-VR improves the health of young adults with diabetes (improves their glycemic control),their feelings of distress (this includes stress, depression, and anxiety), or their mindfulness (being more aware of their thoughts, feelings, actions, and environment) but we will look to see if people are reporting improvements in these areas.
Key Dates
- First listed
- Aug 28, 2026
- Start date
- Sep 15, 2026
- Status verified
- Aug 2026
- Primary completion
- Feb 28, 2028
- Completion
- Feb 28, 2028
Study Design
- Enrollment
- 48 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: MBSR-VRParticipants will receive a 9-week virtually delivered Mindfulness-Based Stress Reduction program enhanced with virtual reality (MBSR-VR). The intervention includes instructor-led mindfulness training, guided meditation practices, and home-based mindfulness exercises delivered remotely using video conferencing and virtual reality technology. Participants will be asked to complete weekly sessions and engage in regular mindfulness practice throughout the intervention period.
- Other: Treatment as Usual (TAU)Emerging adults assigned to TAU will be offered a stress management tip sheet and will otherwise continue to manage their stress using their usual manner. No other treatment services will be offered and they will not be prevented from seeking alternative treatment independent of the research study.
Primary Outcome Measure
Recruitment Feasibility / Number Screened [ Time Frame: From recruitment initiation to recruitment termination / 18 months ]
Central Contacts
- Study Coordinator1-313-577-6997
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins University | Baltimore | Maryland | 21218 | Erica MS Sibinga, MD (PRINCIPAL_INVESTIGATOR) |
| Wayne State University | Detroit | Michigan | 48202 | April Idalski Carcone, PhD, MSW (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Baltimore, MD
Related Studies
- ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2Recruiting · Johns Hopkins University · Baltimore, Maryland
- Family Intervention for Black Teens With Type 1 DiabetesRecruiting · Wayne State University · Washington D.C., District of Columbia
- Registry for Stage 2 Type 1 DiabetesRecruiting · Sanofi · Los Angeles, California
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)PHASE1/PHASE2 · Recruiting · COUR Pharmaceutical Development Company, Inc. · Tucson, Arizona